ries such as Australia and Europe. In the pharmacy of various parts of Australia, lenalidomide cost australia is approximately $20,050 for 28 capsules. A pack of 28 capsules weighs about 2.5 mg.
How Much Does Lenalidomide (Revlimid) cost in Australia?
You can gain discounts on Lenalidomide by the way of insurance and medicare. The pills can be quite expensive if you buy it without private insurance on a monthly basis. Lenalidomide cost (Revlimid) drug costs about $65 every month which is higher than other cancer treatment drugs.
However, many patients seek out a generic version of Lenalidomide Example: Lenalid 5 mg, Lenalid 10 mg, Lenalid 15 mg, Lenalid 25 mg from India which only costs around $ 50 USD – $ 150 depending on the strength order now, For more information please chat with us.
Unlike other medicines and drugs, lenalidomide is not available in a generic version. You have to buy the original version from the pharmacy. You can get the reimbursement of the drugs under schemes such as Medicare programs and Medicare advantage plans.
In addition to that, there are several programs and discount drug cards that can provide Lenalidomide at discounted prices.
Administration of Revlimid (Lenalidomide):
Revlimid (Lenalidomide) is given orally in a form of 25 mg dosage once daily which is taken for 21 days in a 28-day dosage cycle in the morning or evening. Along with Lenalidomide, 40 mg of dexamethasone is given on days 1 to 4, 9 to 12, and 17 to 20 in the same 28-day dosage cycle. Once swallowed, the Lenalidomide is completely absorbed (bioavailable) within 6 hours of administration. Lenalidomide is further metabolized in the liver and distributed throughout the cancerous region. Once it completes its action, subsequently, more than 50% of the dose is expelled from the body within 3 to 5 hours predominantly in the form of urine (90%). In patients with kidney (renal) problems, approximately 40% of Lenalidomide is excreted during a single dialysis session.
An initial dose of Revlimid (Lenalidomide) for renal impairment patients with MM:
As the drug is not readily excreted from the kidney, the initial dosage of Lenalidomide needs to be adjusted in patients with moderate or severe problems in the kidney with MM. The adjustment is very crucial for appropriate drug exposure in such patients. The table below will show the initial dose of Lenalidomide for patients in different stages of kidney problems with MM.
Table: Starting dose of Lenalidomide for renal impairment patients with MM
Category of renal impairment Dose Moderate 10 mg once daily Severe 15 mg once daily End-stage disease 5 mg once daily after the dialysis